CA1341323C - Composition, ainsi qu'une methode, servant a empecher la croissance et la replication de cellules cancereuses comportant le noyau de la glycoproteine de type mucine a - Google Patents

Composition, ainsi qu'une methode, servant a empecher la croissance et la replication de cellules cancereuses comportant le noyau de la glycoproteine de type mucine a Download PDF

Info

Publication number
CA1341323C
CA1341323C CA000617109A CA617109A CA1341323C CA 1341323 C CA1341323 C CA 1341323C CA 000617109 A CA000617109 A CA 000617109A CA 617109 A CA617109 A CA 617109A CA 1341323 C CA1341323 C CA 1341323C
Authority
CA
Canada
Prior art keywords
mucin
antigen
sialyl
pharmaceutical composition
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000617109A
Other languages
English (en)
Inventor
Thomas J. Kjeldsen
Henrik Clausen
Anil Singhal
Tatsushi Toyokuni
Helio Takahashi
Senitiroh Hakomori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomembrane Institute
Original Assignee
Biomembrane Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomembrane Institute filed Critical Biomembrane Institute
Priority claimed from CA000593376A external-priority patent/CA1340587C/fr
Application granted granted Critical
Publication of CA1341323C publication Critical patent/CA1341323C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA000617109A 1988-03-11 1989-03-10 Composition, ainsi qu'une methode, servant a empecher la croissance et la replication de cellules cancereuses comportant le noyau de la glycoproteine de type mucine a Expired - Lifetime CA1341323C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16778688A 1988-03-11 1988-03-11
US167,786 1988-03-11
US31749289A 1989-03-01 1989-03-01
US317,492 1989-03-01
CA000593376A CA1340587C (fr) 1988-03-11 1989-03-10 Mise au point d'un vaccin et d'anticorps monoclonaux contre des antigenes associes au cancer humain, par immunisation avec la mucine animale et humaine et avec des conjugues synthetiques vecteurs d'oligosaccharides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA000593376A Division CA1340587C (fr) 1988-03-11 1989-03-10 Mise au point d'un vaccin et d'anticorps monoclonaux contre des antigenes associes au cancer humain, par immunisation avec la mucine animale et humaine et avec des conjugues synthetiques vecteurs d'oligosaccharides

Publications (1)

Publication Number Publication Date
CA1341323C true CA1341323C (fr) 2001-11-27

Family

ID=27168237

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000617109A Expired - Lifetime CA1341323C (fr) 1988-03-11 1989-03-10 Composition, ainsi qu'une methode, servant a empecher la croissance et la replication de cellules cancereuses comportant le noyau de la glycoproteine de type mucine a

Country Status (1)

Country Link
CA (1) CA1341323C (fr)

Similar Documents

Publication Publication Date Title
US5747048A (en) Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates
Takahashi et al. Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor-associated α-N-acetylgalactosaminyl epitope) that does not cross-react with blood group A antigen
US5660834A (en) Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugates
US5240833A (en) Method for the production of monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides
EP0268279B2 (fr) Hybridomes produisant des anticorps monoclonaux contre des épitopes de la mucine
JP4122050B2 (ja) ヒト癌腫抗原（ｈｃａ）、ｈｃａ抗体、ｈｃａ免疫アッセイ法、画像化の方法及び治療
Rogers Carcinoembryonic antigens and related glycoproteins molecular aspects and specificity
CA1340587C (fr) Mise au point d'un vaccin et d'anticorps monoclonaux contre des antigenes associes au cancer humain, par immunisation avec la mucine animale et humaine et avec des conjugues synthetiques vecteurs d'oligosaccharides
Kudryashov et al. Immunogenicity of synthetic conjugates of Lewis y oligosaccharide with proteins in mice: towards the design of anticancer vaccines
CA2207869A1 (fr) Methode permettant d'induire une reponse immunitaire avec un anticorps bispecifique
EP0381310A1 (fr) Anticorps monoclonaux dirigés contre des gangliosides et fucogangliosides associés aux tumeurs et méthode pour leur production
Kannagi et al. Recent studies of glycolipid and glycoprotein profiles and characterization of the major glycolipid antigen in gastric cancer of a patient of blood group genotype pp (Tja-) first studied in 1951
Ito et al. Carbohydrates as antigenic determinants of tumor‐associated antigens recognized by monoclonal anti‐tumor antibodies produced in a syngeneic system
US4894442A (en) Monoclonal antibodies that bind to alpha-acid glycoprotein
US5876716A (en) Method of using an antibody to the TN antigen for the inhibition of HIV infection
CA1341323C (fr) Composition, ainsi qu'une methode, servant a empecher la croissance et la replication de cellules cancereuses comportant le noyau de la glycoproteine de type mucine a
KR960014441B1 (ko) 알파 2-3 결합을 인지하는 단일클론성 항체
EP0218257B1 (fr) Anticorps monoclonal spécifique de l'adénocarcinome pulmonaire humain
EP0274847B1 (fr) Antigènes-H associes-A, anticorps monoclonaux spécifiques et méthodes les utilisant dans la détermination des groupes sanguins
US5073493A (en) Monoclonal antibody nky13
EP0162825A2 (fr) Utilisation d'un antigène spécifique (haptène) associé au carcinome, fucosylsialosylgangliotétrose (Fuc-GM1) dans des méthodes diagnostiques ou thérapeutiques en relation avec le cancer du poumon humain (carcinome de petite cellule)
EP0511967B1 (fr) Procedes et medicaments de traitement du syndrome d'immunodeficience acquise (sida) et du complexe apparente au sida (arc) au moyen d'anticorps anti-glucides
EP0369425A1 (fr) Anticorps monoclonal à spécificité pour le GM2 du type N-glycolyl, hybridome producteur de l'anticorps et méthode pour la préparation de l'hybridome
Perico et al. Development of a new vaccine formulation that enhances the immunogenicity of tumor-associated antigen CaMBr1
Hanisch et al. Immunochemistry of O-glycosidically-linked Gal (β1→ 3) GalNac on fragments of human glycophorin A

Legal Events

Date Code Title Description
MKEX Expiry

Effective date: 20181127